| Literature DB >> 21941639 |
Maria Waling1, Catharina Bäcklund, Torbjörn Lind, Christel Larsson.
Abstract
Objective. To evaluate the effect of a family-based intervention on anthropometric and metabolic markers in overweight and obese children. Methods. Overweight or obese 8-12 years olds (n = 93) were randomized into intervention or control groups. The intervention group participated in a program aiming for lifestyle changes regarding food habits and physical activity. Anthropometric measures and venous blood samples were collected from all children at baseline and after 1 year. Results. BMI z-scores decreased in both groups, 0.22 (P = 0.002) and 0.23 (P = 0.003) in intervention and control group, respectively, during the 1-year study, but there was no difference in BMI between the groups at 1-year measurement (P = 0.338). After 1 year, there was a significant difference in waist circumference, waist/hip ratio, and apolipoprotein B/A1 ratio between intervention and control group. Conclusions. The intervention had limited effects on anthropometrics and metabolic markers, which emphasizes the need of preventing childhood overweight and obesity.Entities:
Year: 2011 PMID: 21941639 PMCID: PMC3176428 DOI: 10.1155/2012/913965
Source DB: PubMed Journal: J Nutr Metab ISSN: 2090-0724
Figure 1Flowchart of participants in a 1 year randomized controlled intervention study with overweight and obese children.
Baseline characteristics; anthropometric measures, and fasting blood values, of overweight and obese children presented as mean (standard deviation).
| Intervention group | Control group |
| |
|---|---|---|---|
| Age (years) | 10.5 (1.15) | 10.5 (1.02) | 0.914 |
| Weight (kg) | 52.1 (9.95) | 50.4 (9.99) | 0.402 |
| Height (cm) | 149 (7.86) | 149 (8.64) | 0.951 |
| BMI (kg/m2) | 23.4 (2.79) | 22.6 (2.39) | 0.148 |
| BMI | 2.03 (0.88) | 1.77 (0.71) | 0.130 |
| BMI | 3.23 (1.34) | 2.75 (1.04) | 0.057 |
| Waist circumference (cm) | 78.0 (10.1) | 74.7 (8.80) | 0.094 |
| Hip circumference (cm) | 89.4 (7.53) | 87.1 (7.57) | 0.145 |
| Waist/hip ratio | 0.87 (0.07) | 0.86 (0.07) | 0.352 |
| Sagittal abdominal diameter (cm) | 17.6 (2.53) | 17.0 (1.82) | 0.153 |
| Fat mass (kg) | 19.8 (6.19) | 17.9 (4.97) | 0.121 |
| Fat mass (%) | 39.2 (6.17) | 37.0 (4.33) |
|
| Truncal fat mass (%) | 38.4 (7.46) | 36.2 (5.42) | 0.115 |
| Diastolic blood pressure (mm Hg) | 66.6 (5.60) | 66.7 (6.14) | 0.959 |
| Systolic blood pressure (mm Hg) | 112 (8.92) | 113 (8.80) | 0.739 |
| Total cholesterol (mmol/L) | 4.44 (0.91) | 4.51 (0.82) | 0.711 |
| LDL-cholesterol (mmol/L) | 2.58 (0.78) | 2.71 (0.74) | 0.415 |
| HDL-cholesterol (mmol/L) | 1.46 (0.32) | 1.35 (0.28) | 0.104 |
| Triglycerides (mmol/L) | 0.88 (0.53) | 0.95 (0.39) | 0.498 |
| Apolipoprotein B (mg/L) | 745 (173) | 782 (174) | 0.316 |
| Apolipoprotein A1 (mg/L) | 1350 (182) | 1330 (169) | 0.708 |
| Apolipoprotein B/A1 ratio | 0.56 (0.14) | 0.59 (0.14) | 0.280 |
| Glucose (mmol/L) | 4.52 (0.43) | 4.65 (0.42) | 0.157 |
| Insulin (mU/L) | 10.3 (6.77) | 10.2 (6.82) | 0.976 |
| HOMA-index | 2.06 (1.37) | 2.18 (1.65) | 0.722 |
| Hb A1c (%) | 4.03 (0.24) | 3.98 (0.27) | 0.337 |
*One child refused to give a blood sample.
**P value for difference between groups from independent samples t-test.
***Reference population from CDC in the USA [21].
†Reference population from a Swedish population-based study [22].
Proportion of normal weight, overweight and obesity among overweight, and obese children, presented as number (%).
| Baseline | 1 year | |||||
|---|---|---|---|---|---|---|
| Intervention | Control |
| Intervention | Control |
| |
| BMI** | ||||||
| Normal weight | 2 (4) | 1 (2) | 4 (8) | 7 (16) | ||
| Overweight | 28 (58) | 33 (73) | 0.311 | 30 (63) | 29 (64) | 0.431 |
| Obese | 18 (38) | 11 (24) | 14 (29) | 9 (20) | ||
*Difference in proportions between intervention group and control group analyzed with Chi-square test.
**Classification according to IOTF [16].
Anthropometric measures and fasting blood values after a 1-year intervention in overweight and obese children presented as mean (standard deviation).
| Intervention group | Control group | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last observation carried forward | Per protocol | Last observation carried forward | Per protocol | |||||||||||
| ( | ( | ( | ( | |||||||||||
| 1 year | Change from baseline |
| 1 year | Change from baseline |
| 1 year | Change from baseline |
| 1 year | Change from baseline |
|
|
| |
| Weight (kg) | 54.9 (10.4) | 2.78 (0.50) |
| 56.5 (11.4) | 4.76 (3.29) |
| 54.0 (11.7) | 3.65 (4.17) |
| 55.4 (11.5) | 5.47 (4.01) |
| 0.509 | 0.207 |
| Height (cm) | 152 (8.38) | 3.67 (3.36) |
| 154 (9.55) | 6.29 (1.59) |
| 153 (9.33) | 4.48 (3.53) |
| 155 (8.33) | 6.71 (1.82) |
| 0.324 | 0.402 |
| BMI (kg/m2) | 23.5 (2.70) | 0.08 (0.95) | 0.572 | 23.7 (2.74) | 0.13 (0.24) | 0.576 | 22.8 (2.86) | 0.20 (1.12) | 0.240 | 22.9 (3.00) | 0.30 (1.37) | 0.242 | 0.747 | 0.338 |
| BMI | 1.81 (0.82) | −0.22 (0.37) |
| 1.71 (0.81) | −0.37 (0.08) |
| 1.55 (0.82) | −0.23 (0.48) |
| 1.52 (0.90) | −0.34 (0.56) |
| 0.844 | 0.523 |
| BMI | 2.94 (1.22) | −0.29 (0.62) |
| 2.79 (1.19) | −0.50 (0.74) |
| 2.57 (1.21) | −0.18 (0.59) | 0.050 | 2.56 (1.32) | −0.27 (0.71) | 0.050 | 0.536 | 0.432 |
| Fat mass index (kg fat/m2) | 13.4 (3.68) | 0.25 (1.25) | 0.171 | 13.7 (3.86) | 0.47 (1.65) | 0.154 | 12.5 (3.65) | 0.55 (1.60) |
| 12.8 (4.06) | 0.84 (1.93) |
| 0.318 | 0.432 |
| Waist circumference (cm) | 79.3 (9.99) | 1.29 (3.97) |
| 80.2 (9.75) | 2.21 (5.04) |
| 78.1 (9.14) | 3.49 (6.44) |
| 79.8 (9.34) | 5.23 (7.31) |
|
| 0.211 |
| Hip circumference (cm) | 90.4 (7.65) | 1.07 (2.82) |
| 91.0 (7.50) | 1.84 (3.52) |
| 89.0 (8.29) | 1.96 (3.98) |
| 90.0 (8.03) | 2.94 (4.58) |
| 0.932 | 0.119 |
| Waist/hip ratio | 0.88 (0.07) | 0.00 (0.03) | 0.393 | 0.88 (0.06) | 0.01 (0.04) | 0.397 | 0.88 (0.06) | 0.02 (0.06) |
| 0.89 (0.06) | 0.03 (0.08) |
|
| 0.449 |
| Sagittal abdominal diameter (cm) | 17.9 (2.22) | 0.28 (1.14) | 0.097 | 18.2 (2.09) | 0.48 (1.48) | 0.098 | 17.5 (2.29) | 0.54 (1.28) |
| 17.9 (2.26) | 0.82 (1.50) |
| 0.590 | 0.387 |
| Fat mass (kg) | 20.6 (6.31) | 0.88 (2.07) |
| 21.3 (6.84) | 2.92 (1.51) |
| 19.3 (6.37) | 1.43 (2.66) |
| 20.0 (6.94) | 2.19 (3.04) |
| 0.483 | 0.329 |
| Fat mass (%) | 39.0 (6.11) | −0.21 (2.26) | 0.514 | 39.0 (5.55) | −0.39 (3.06) | 0.519 | 36.9 (5.82) | −0.16 (3.34) | 0.761 | 36.8 (6.67) | −0.24 (4.16) | 0.763 | 0.965 | 0.957 |
| Truncal fat mass (%) | 38.0 (7.47) | −0.38 (2.63) | 0.312 | 38.2 (7.22) | −0.70 (3.54) | 0.316 | 35.9 (7.46) | −0.29 (3.98) | 0.640 | 35.8 (8.48) | −0.44 (4.96) | 0.643 | 0.830 | 0.780 |
| Diastolic blood pressure (mm Hg) | 66.7 (5.44) | 0.10 (3.49) | 0.837 | 67.8 (5.06) | 0.18 (0.87) | 0.839 | 66.6 (6.00) | −0.07 (5.07) | 0.929 | 67.5 (5.74) | −0.10 (6.28) | 0.930 | 0.272 | 0.789 |
| Systolic blood pressure (mm Hg) | 111 (8.58) | −0.58 (5.81) | 0.490 | 112 (8.89) | −1.00 (7.64) | 0.494 | 114 (9.28) | 1.38 (6.99) | 0.193 | 115 (8.55) | 2.07 (8.52) | 0.194 | 0.758 | 0.218 |
| Total cholesterol (mmol/L) | 4.32 (0.91) | −0.12 (0.49) | 0.087 | 4.10 (0.76) | −0.21 (0.63) | 0.087 | 4.33 (0.82) | −0.18 (0.37) |
| 4.27 (0.73) | −0.27 (0.42) |
| 0.520 | 0.729 |
| LDL-cholesterol (mmol/L) | 2.54 (0.78) | −0.05 (0.33) | 0.342 | 2.39 (0.62) | −0.79 (0.43) | 0.346 | 2.64 (0.75) | −0.08 (0.35) | 0.159 | 2.57 (0.76) | −0.11 (0.42) | 0.160 | 0.828 | 0.704 |
| HDL-cholesterol (mmol/L) | 1.39 (0.35) | −0.07 (0.18) |
| 1.32 (0.32) | −0.12 (0.22) |
| 1.28 (0.29) | −0.07 (0.15) |
| 1.30 (0.30) | −0.10 (0.18) |
| 0.983 | 0.513 |
| LDL/HDL ratio | 1.91 (0.60) | 0.06 (0.27) | 0.115 | 1.89 (0.52) | 0.11 (0.35) | 0.115 | 2.16 (0.74) | 0.10 (0.42) | 0.136 | 2.13 (0.87) | 0.14 (0.51) | 0.137 | 0.711 | 0.846 |
| Triglycerides (mmol/L) | 0.87 (0.63) | −0.01 (0.43) | 0.825 | 0.86 (0.59) | −0.02 (0.56) | 0.827 | 0.89 (0.40) | −0.06 (0.44) | 0.338 | 0.88 (0.43) | −0.10 (0.54) | 0.341 | 0.286 | 0.732 |
| Apolipoprotein B (g/L) | 0.73 (0.17) | −0.01 (0.07) | 0.243 | 0.70 (0.13) | −20 (0.08) | 0.246 | 0.76 (0.16) | −0.03 (0.09) |
| 0.79 (0.16) | −0.04 (0.10) |
| 0.860 | 0.907 |
| Apolipoprotein A1 (g/L) | 1.29 (0.20) | −0.05 (0.13) |
| 1.25 (0.18) | −0.09 (0.16) |
| 1.23 (0.15) | −0.10 (0.15) |
| 1.22 (0.14) | −0.16 (0.16) |
| 0.060 | 0.411 |
| Apolipoprotein B/A1 ratio | 0.57 (0.13) | 0.01 (0.05) | 0.134 | 0.56 (0.11) | 0.02 (0.07) | 0.135 | 0.62 (0.13) | 0.03 (0.08) |
| 0.61 (0.15) | 0.04 (0.02) |
|
| 0.342 |
| Glucose (mmol/L) | 4.58 (0.42) | 0.06 (0.25) | 0.132 | 4.62 (0.36) | 0.09 (0.33) | 0.133 | 4.62 (0.41) | −0.02 (0.27) | 0.623 | 4.64 (0.38) | −0.31 (0.34) | 0.626 | 0.565 | 0.494 |
| Insulin (mU/L) | 11.2 (5.76) | 0.90 (4.09) | 0.136 | 12.1 (4.90) | 1.54 (5.30) | 0.137 | 10.4 (5.71) | 0.21 (5.37) | 0.797 | 10.7 (5.62) | 0.32 (6.64) | 0.799 | 0.699 | 0.660 |
| HOMA-index | 2.28 (1.19) | 0.21 (0.93) | 0.122 | 2.49 (1.08) | 0.36 (1.21) | 0.123 | 2.20 (1.34) | 0.02 (1.26) | 0.896 | 2.26 (1.33) | 0.04 (1.56) | 0.897 | 0.827 | 0.716 |
| HbA1c (%) | 4.11 (0.23) | 0.07 (0.15) |
| 4.15 (0.24) | 0.13 (0.19) |
| 4.03 (0.27) | 0.04 (0.13) |
| 4.08 (0.26) | 0.07 (0.16) |
| 0.612 | 0.127 |
*One child refused to give blood sample.
**P values for difference between baseline and 1-year analyzed by paired samples t-test.
***P values for difference between groups at 1-year analyzed by the last observation carried forward principle with a one-way analysis of covariance.
† P values for difference between groups at 1-year analyzed per protocol with a one-way analysis of covariance.
††Reference population from the US [21].
†††Reference population from Sweden [22].